The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine -- the nation's only traditional ...

Novavax said Monday that the Food and Drug Administration was asking the company to run a new clinical trial of its vaccine.

In an interview with Dr. Phil, the health secretary offered false information about vaccine oversight and revealed a lack of ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.

There is common ground. Most adults favor: Preventing chronic diseases (Republicans 86%, Democrats 91%) Protecting against ...

The FDA and other HHS agencies of interest to the pharma sphere have seen President Donald Trump’s first 100 days as he ...

Among other things, Makary breaks some news here by stating, for the first time, that there will be no significant ...

A group of public health experts and scientists is mobilizing to counter vaccine misinformation from federal agencies, in an ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.